Trials / Completed
CompletedNCT04951193
Goal2QuitVaping for Nicotine Vaping Cessation Among Adolescents
Development and Evaluation of a Brief Behavioral Activation Mobile Application for Nicotine Vaping Cessation Among Adolescent Primary Care Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 16 Years – 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate a mobile application (app) called "Goal2QuitVaping" to help adolescents quit vaping nicotine. Goal2QuitVaping was developed by our research team to assist with quitting vaping. Participants will be randomly assigned to either download the mobile app, "Goal2QuitVaping", or not. If provided with Goal2QuitVaping, participants will be asked to use the app regularly, at least once per day, throughout the study duration. Participants will be asked to complete electronic questionnaire measures throughout the study period. Participation in this study will take about 4 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Behavioral Activation Therapy app | Goal2QuitVaping focuses on tracking daily activities, recording daily mood, and identifying new activities to complete that may help improve mood. Participants will be asked to complete questionnaire measures weekly for 4 weeks following study enrollment. |
| BEHAVIORAL | Treatment as Usual | Participants will be provided educational material about quitting vaping nicotine with the suggestion to discuss questions with their PCP. Participants will be asked to complete questionnaire measures weekly for 4 weeks following study enrollment. |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2023-05-24
- Completion
- 2023-06-21
- First posted
- 2021-07-06
- Last updated
- 2024-08-21
- Results posted
- 2024-06-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04951193. Inclusion in this directory is not an endorsement.